Drug Price Lookup
Live pharmacy acquisition cost (CMS NADAC) for any US drug — by strength, with effective dates.
Octreotide (brands: BYNFEZIA Pen, Mycapssa, Octreotide)
| Strength | Acquisition cost | Effective |
|---|---|---|
| 10 MG | $3523.0291/unit | 07/08/2026 |
| 100 MCG/ML | $2.6792/unit | 10/21/2026 |
| 1000 MCG/5 Vial | $5.3404/unit | 04/22/2026 |
| 20 MG | $4588.5469/unit | 07/08/2026 |
| 30 MG | $6948.0840/unit | 07/08/2026 |
| 50 MCG/ML Vial | $2.6422/unit | 04/22/2026 |
Full profile — coverage, spending, alternatives: rxfinder.ai/drug/octreotide
NADAC is what pharmacies actually pay to acquire the drug — the honest baseline for judging what a plan is charged.
Data: CMS NADAC (National Average Drug Acquisition Cost) — NADAC effective 07/08/2026 · source
Machine access — this tool is available as structured data for AI assistants and agents:
GET https://rxfinder.ai/tools/drug-price/data.json?drug=octreotide